Investing lessons from Kipchoge Bolt: Your goal should decide the right choice
Usain Bolt of Jamaica and Eliud Kipchoge of Kenya are two of the world’s legendary athletes. Bolt recently retired from athletics, but both are current world record holders in their respective events – 100 metre sprint and marathon.

Usain Bolt’s record in the 100-metre sprint stands at 9.58 seconds. Eliud Kipchoge’s record at the marathon is a tim

Write comment (94 Comments)
The three months to December could turn out to be rather disappointing for investors in cement stocks as prices remain stagnant, or show insignificant growth, in a quarter that marks the beginning of the seasonally strong period of demand for the industry.

According to various estimates, in the past two weeks, cement players have been unable to

Write comment (97 Comments)
MUMBAI: Private equity firm True North is in advanced talks to buy a large stake in Max Bupa Health Insurance, a joint venture between Max India and the UK-based healthcare services expert, Bupa, said two people aware of the development. The deal is likely to value Max Bupa at Rs 1,700 crore.

“The talks are in an advanced stage between True North a

Write comment (97 Comments)
YES Bank climbs 3%, says on track to name new CEO within RBI deadline
NEW DELHI: Shares of YES Bank climbed 3 per cent in morning trade on Friday, a day after suffering a loss of 6.48 per cent, as the lender deferred the appointment of managing director and CEO to January 9.

The committee and board on Thursday finalised the recommendation for the position of non-executive part-time chairman and shall be promptly

Write comment (97 Comments)
Buy Infosys, target Rs 715: Kunal Bothra
Independent analyst Kunal Bothra has a buy call on Infosys Ltd. with a target price of Rs 715. The current market price of Infosys Ltd. is Rs 702.95. Time period given by the analyst is Intra Day when Infosys Ltd. price can reach the defined target. Kunal Bothra recommended to keep stoploss at Rs 680.

Infosys Ltd., incorporated in 1981, is a

Write comment (91 Comments)
Share market update: IT shares fall; MindTree down nearly 2%
NEW DELHI: The Nifty IT index was trading 0.38 per cent down at 14,683.25 on Thursday with most of its components trading in the red.

Shares of MindTree (down 1.67 per cent), Tata Consultancy Services (down 1.27 per cent), Tata Elxsi (down 0.93 per cent) and Tech Mahindra (down 0.88 per cent) were the top losers in the index.

HCL Technologies

Write comment (98 Comments)
IOC rises nearly 3% after company announces share buyback
Shares of Indian Oil Corporation rose nearly 3 per cent in early trade on Friday after the company announced a buyback of 3.06 per cent equity shares at a price of Rs 149 per stock for a consideration not exceeding Rs 4,435 crore.The buyback decision was taken by the company's board in its meeting held on Thursday. The company board also

Write comment (99 Comments)
Buy Glenmark Pharmaceuticals, target Rs 715: Kunal Bothra
Independent analyst Kunal Bothra has a buy call on Glenmark Pharmaceuticals Ltd. with a target price of Rs 715. The current market price of Glenmark Pharmaceuticals Ltd. is Rs 677.05. Time period given by the analyst is Intra Day when Glenmark Pharmaceuticals Ltd. price can reach defined target. Kunal Bothra recommended to keep stoploss at Rs 655.

Write comment (96 Comments)
Tata Sponge to seek EGM nod for preference issue to Tata Steel
KOLKATA: Tata Sponge Iron (TSIL) has called an extraordinary general meeting (EGM) on December 14 to seek approval for issue of preference shares on private placement basis to its promoter, Tata Steel, for up to Rs 1,000 crore.

Tata Steel recently announced TSIL as its vehicle for acquisition of Usha Martin’s steel business in a deal size of Rs 4

Write comment (91 Comments)
Khaitan, Palred Tech among top losers on BSE
NEW DELHI: The domestic equity benchmark BSE Sensex was trading 70.97 points up at 36,000.61 on Friday on account of buying in frontline bluechip counters.

Shares of Sumuka Agro Industries (down 19.55 per cent), Khaitan (India) (down 12.76 per cent), Resonance Specialities (down 12.73 per cent), Prime Customer Services (down 10.87 per cent),

Write comment (95 Comments)
Fund managers of some large- and multi-cap schemes have been buying the Nifty futures in a bid to boost returns. A look at the factsheets of large fund houses shows that some schemes have added Nifty futures to the tune of 1-9 per cent in their portfolio as of November 2018.

Schemes such as ICICI Prudential Value Discovery, Axis Multicap, Axis

Write comment (91 Comments)
DLF defers 173 million share issue; group CFO resigns
MUMBAI: Realty developer DLF deferred a planned private placement of 173 million shares that was part of the company’s fund-raising exercise to become debt-free by March 2019.

The board decided to seek fresh shareholder approval for the issue, with the current validity set to end on December 26, DLF said in a stock exchange filing on Wednesday.

Sep

Write comment (96 Comments)
Sensex, Nifty off to a weak start amid weak global sentiment
NEW DELHI: Market took a pause after three successive sessions of bullish run and tumbled in early trade on Friday in the wake of weak global sentiment arising from the concerns of slowing global growth.

A set of data that showed a slowdown in China's economy fanned worries that the world's second largest economy was witnessing an economic

Write comment (95 Comments)
Buy Wipro, target Rs 347: Dr CK Narayan
Dr CK Narayan of Chart Advise has a buy call on Wipro Ltd. with a target price of Rs 347. The current market price of Wipro Ltd. is Rs 338.75 Time period given by analyst is Intra Day when Wipro Ltd. price can reach defined target. Dr CK Narayan recommended to keep stoploss at Rs 334. Wipro Ltd., incorporated in 1945, is a largecap company with a

Write comment (96 Comments)
YES Bank climbs 4% ahead of board meeting
NEW DELHI: Shares of YES Bank climbed 4 per cent in the morning trade on Thursday ahead of the company's board meeting wherein it will recommend names for a new chairman for RBI's approval.

The private lender had said last month that on December 13, its board will recommend names for a new chairman to be approved by the RBI, as well as consider

Write comment (98 Comments)
Buzzing stocks: RCom, YES Bank, IOC, Motherson Sumi, Indiabulls Housing Finance
NEW DELHI: YES Bank with over 2.80 crore shares changing hands was leading among the most traded stocks on NSE on Friday.

Shares of PC Jeweller (number of shares traded: 1.75 crore), Motherson Sumi (number of shares traded: 1.17 crore), Indian Oil Corp (number of shares traded: 1.13 crore), Reliance Communications (number of shares traded: 0.91

Write comment (92 Comments)
Buy SRF, target Rs 2210: Dr CK Narayan
Dr CK Narayan of Chart Advise has a buy call on SRF Ltd. with a target price of Rs 2210. The current market price of SRF Ltd. is Rs 2182.8. Time period given by the analyst is Intra Day when SRF Ltd. price can reach the defined target. Dr CK Narayan recommended to keep stoploss at Rs 2160. SRF Ltd., incorporated in 1970, is a midcap company with a

Write comment (92 Comments)
Share market update: Auto shares in the green; Bosch, Tata Motors among top gainers
NEW DELHI: Auto shares were trading with strong gains with the Nifty Auto index up 0.67 per cent at 9227.15 on Thursday.

Shares of Bosch (up 1.84 per cent), Tata Motors (DVR) (up 1.84 per cent), Motherson Sumi Systems (up 1.56 per cent) and Bharat Forge (up 1.53 per cent) were the top gainers in the index.

Tata Motors (up 1.46 per cent), Maruti

Write comment (95 Comments)
Motherson Sumi surges nearly 10% as company eyes deal with Leoni
Shares of Motherson Sumi surged nearly 10 per cent in early trade on Friday after media reports suggested that the company is in talks to acquire or merge with Germany-based Leoni, the largest maker of special automotive cables globally.

Leoni is listed on German exchange and has a market capitalisation of €1.03 billion. The N

Write comment (96 Comments)
Top intraday trading ideas for afternoon trade for Thursday 13 December 2018
NEW DELHI: Equity benchmarks Sensex and Nifty50 were trading higher on Thursday on account of buying in frontline bluechip counters.

ETMarkets.com collated a list of trading ideas from various experts and here's what they had recommended for today's afternoon trade:

Manas Jaiswal of manasjaiswal.comGlenmark Pharma is a 'Buy' call with a target

Write comment (99 Comments)
Share market update: PSU Bank shares gain; Indian Bank up nearly 5%
NEW DELHI: PSU Bank shares were trading in the green with the Nifty PSU Bank index up 2.17 per cent at 3004.55 on Thursday.

Shares of Indian Bank (up 4.66 per cent), State Bank of India (up 2.38 per cent), Central Bank of India (up 2.34 per cent) and Union Bank of India (up 1.75 per cent) were the top performers in the index.

Bank of India (up

Write comment (92 Comments)
The sun is yet to pierce the veil of brooding regulatory clouds and shine on India’s biggest pharma company, leaving investors with only a handful of alternative investment choices in a sector that theoretically holds great promise.

As a regulatory investigation continues into Sun Pharma over whistleblower complaints, the stock’s revival from m

Write comment (93 Comments)
Technology as a category stood out as the only oasis for mutual fund investors this calendar, as it managed to deliver double-digit returns to investors over the last one year.

Despite strong volatility in the broader market for much of 2018, all the five IT-focussed mutual funds – Tata Digital India Fund, SBI Technology Opportunities Fund, ICICI P

Write comment (93 Comments)
By Subhadip Sircar

Bonds bulls in India have more reasons to cheer this week. Receding inflation pressure and a new central bank governor widely seen to have a dovish bent mean the swap markets have started pricing in interest-rate cuts.

One-year onshore swap rates are factoring a 50 percent chance of a reduction around April or June, or 100

Write comment (99 Comments)
Buy Infosys, target Rs 725: Manas Jaiswal
Manas Jaiswal of manasjaiswal.com has a buy call on Infosys Ltd. with a target price of Rs 725. The current market price of Infosys Ltd. is Rs 701.25. Time period given by analyst is Intra Day when Infosys Ltd. price can reach defined target. Manas Jaiswal recommended to keep stoploss at Rs 680. Infosys Ltd., incorporated in 1981, is a largecap

Write comment (92 Comments)
Share market update: Nifty Pharma index flat; Piramal Enterprises rises 3%
NEW DELHI: The Nifty Pharma index was trading up 0.08 per cent at 8808.45 on Thursday with most of its components trading in the green.

Shares of Piramal Enterprises (up 3.20 per cent), Glenmark Pharmaceuticals (up 2.30 per cent), Lupin (up 1.50 per cent) and Aurobindo Pharma (up 0.61 per cent) were the top gainers in the index.

Cadila

Write comment (90 Comments)
Escorts stock has gained 9 per cent since Monday following the announcement of its joint venture (JV) with Japan’s Kubota to manufacture high-end products. The gain was over and above the 3.5 per cent drop in the stock price soon after the JV was announced. The fall reflected market’s concern over the possibility of margin dilution after the JV. Ho

Write comment (94 Comments)
Buy Glenmark Pharmaceuticals, target Rs 710: Manas Jaiswal
Manas Jaiswal of manasjaiswal.com has a buy call on Glenmark Pharmaceuticals Ltd. with a target price of Rs 710. The current market price of Glenmark Pharmaceuticals Ltd. is Rs 681.35. Time period given by the analyst is Intra Day when Glenmark Pharmaceuticals Ltd. price can reach the defined target. Manas Jaiswal recommended to keep stoploss at

Write comment (100 Comments)
Share market update: Over 20 stocks hit 52-week lows on NSE
NEW DELHI: Around 22 stocks fell to touch their 52-week lows on NSE in Thursday's session.

Among the stocks that touched their 52-week lows were GTL Infra, Kewal Kiran Clothing, Rolta India, Tara Jewels, TCI Developers and Viji Finance.

Ankit Metal Power, Nagarjuna Oil, TCI Developers, Zylog Systems and Ashapura Intimates also featured among the

Write comment (94 Comments)
Sun Pharma declines 3% as Sebi confirms whistleblower complaint
NEW DELHI: Shares of Sun Pharma, India’s largest drugmaker, declined 3 per cent in morning trade on Thursday, a day after the Securities Exchange Board of India (Sebi) confirmed reports that it had received a whistleblower complaint against the company.

"We have received the complaint against Sun Pharma and we are examining it", Sebi chairman Ajay

Write comment (99 Comments)